Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 1/2019

01.08.2018 | Original Article

Red Cell Indices and Hemoglobin Profile of Newborn Babies with Both the Sickle Gene and Alpha Thalassaemia in Central India

verfasst von: Dipti Upadhye, Dipty Jain, Anita Nadkarni, Kanjaksha Ghosh, Roshan Colah

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

This study evaluated the effect of alpha thalassemia on the red cell indices and hemoglobin profiles of normal, sickle heterozygous and sickle homozygous newborn babies in central India where the sickle gene is linked to the Arab-Indian haplotype. 265 newborn babies were analysed with complete blood count and hemoglobin analysis on high performance liquid chromatography (Variant Hb Testing System, BioRad Laboratories, Hercules, CA, USA) using the β-thal short program. The sickle genotypes was confirmed by DNA analysis. The two common alpha gene deletions (− α3.7 and − α4.2) were detected by multiplex PCR. Among the 102 normal, 106 sickle heterozygous and 57 sickle homozygous newborns, the prevalence of a single alpha gene deletion (− α/αα) was 28.3% and that of deletion of 2 alpha genes (− α/− α) was 21.5%. In all, 57 normal (55.9%), 35 (33.0%) sickle heterozygous and 41 (71.9%) sickle homozygous newborns had a normal α genotype while − α/− α was seen in 23 (22.5%) normal, 30 (28.3%) sickle heterozygous and 4 (7.0%) sickle homozygous newborns respectively. The presence of associated alpha thalassemia resulted in a reduction in the hemoglobin levels and red cell indices in normal, sickle heterozygous and sickle homozygous newborn babies, MCV and MCH being strong discriminators of alpha thalassemia with two alpha gene deletions in all the three groups. This study also helped us to know the variations in hematological parameters in normal, sickle heterozygous and sickle homozygous newborns with and without associated α thalassemia.
Literatur
2.
Zurück zum Zitat Nadkarni A, Phanasgaonkar S, Colah R, Mohanty D, Ghosh K (2008) Prevalence and molecular characterization of α-thalassemia syndromes among Indians. Genet Test 12(2):177–180CrossRefPubMed Nadkarni A, Phanasgaonkar S, Colah R, Mohanty D, Ghosh K (2008) Prevalence and molecular characterization of α-thalassemia syndromes among Indians. Genet Test 12(2):177–180CrossRefPubMed
3.
Zurück zum Zitat Embury SH, Dozy AM, Miller J, Davis JR, Kleman KM, Preisler H, Vichinsky E, Lande WN, Lubin BH, Kan YW, Mentzer WC (1982) Concurrent sickle-cell anemia and alpha thalassemia: effect on severity of anemia. N Engl J Med 306(5):270–274CrossRefPubMed Embury SH, Dozy AM, Miller J, Davis JR, Kleman KM, Preisler H, Vichinsky E, Lande WN, Lubin BH, Kan YW, Mentzer WC (1982) Concurrent sickle-cell anemia and alpha thalassemia: effect on severity of anemia. N Engl J Med 306(5):270–274CrossRefPubMed
4.
Zurück zum Zitat Steinberg MH, Rosenstock W, Coleman MB, Adams JG, Platica O, Cedeno M, Rieder RF, Wilson JT, Milner P, West S (1984) Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia. Blood 63(6):1353–1360PubMed Steinberg MH, Rosenstock W, Coleman MB, Adams JG, Platica O, Cedeno M, Rieder RF, Wilson JT, Milner P, West S (1984) Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia. Blood 63(6):1353–1360PubMed
5.
Zurück zum Zitat Bain BJ, Lewis SM, Bates I (2006) Basic hematological techniques. In: Lewis SM, Bain BJ, Bates I (eds) Dacie and Lewis practical hematology, 10th edn. Churchill Livingstone, Philadelphia, p 25CrossRef Bain BJ, Lewis SM, Bates I (2006) Basic hematological techniques. In: Lewis SM, Bain BJ, Bates I (eds) Dacie and Lewis practical hematology, 10th edn. Churchill Livingstone, Philadelphia, p 25CrossRef
6.
Zurück zum Zitat Colah RB, Gorakshakar AC, Lu CY, Nadkarni AH, Desai SN, Pawar AR, Lulla CP, Krishnamoorthy R, Mohanty D (1997) Application of covalent reverse dot blot hybridisation for rapid prenatal diagnosis of the common Indian thalassemia syndromes. Ind J Hematol Blood Transf 15(1):10–13 Colah RB, Gorakshakar AC, Lu CY, Nadkarni AH, Desai SN, Pawar AR, Lulla CP, Krishnamoorthy R, Mohanty D (1997) Application of covalent reverse dot blot hybridisation for rapid prenatal diagnosis of the common Indian thalassemia syndromes. Ind J Hematol Blood Transf 15(1):10–13
7.
Zurück zum Zitat Tan AS, Quah TC, Low PS, Chong SS (2001) A rapid and reliable 7 deletion multiplex polymerase chain reaction assay for α thalassemia. Blood 98(1):250–251CrossRefPubMed Tan AS, Quah TC, Low PS, Chong SS (2001) A rapid and reliable 7 deletion multiplex polymerase chain reaction assay for α thalassemia. Blood 98(1):250–251CrossRefPubMed
8.
Zurück zum Zitat Tritipsombut J, Sanchaisuriya K, Fucharoen S, Fucharoen G, Siriratmanawong N, Pinmuang-ngam C, Sanchaisuriya P (2008) Hemoglobin profiles and hematologic features of thalassemic newborns: application to screening of alpha-thalassemia 1 and hemoglobin E. Arch Pathol Lab Med 132(11):1739–1745PubMed Tritipsombut J, Sanchaisuriya K, Fucharoen S, Fucharoen G, Siriratmanawong N, Pinmuang-ngam C, Sanchaisuriya P (2008) Hemoglobin profiles and hematologic features of thalassemic newborns: application to screening of alpha-thalassemia 1 and hemoglobin E. Arch Pathol Lab Med 132(11):1739–1745PubMed
9.
Zurück zum Zitat Charoenkwan P, Taweephol R, Sirichotiyakul SI, Tantiprabha Sae-Tung WR, Suanta S (2010) Cord blood screening for α- thalassemia and hemoglobin variants by isoelectric focusing in northern Thai neonates: correlation with genotypes and hematologic parameters. Blood Cell Mol Dis 45(1):53–57CrossRef Charoenkwan P, Taweephol R, Sirichotiyakul SI, Tantiprabha Sae-Tung WR, Suanta S (2010) Cord blood screening for α- thalassemia and hemoglobin variants by isoelectric focusing in northern Thai neonates: correlation with genotypes and hematologic parameters. Blood Cell Mol Dis 45(1):53–57CrossRef
10.
Zurück zum Zitat Quadri MI, Islam SI, Nasserullah Z (2000) The effect of α-thalassemia on cord blood red cell indices and interaction with sickle cell gene. Ann Saudi Med 20(5–6):367–370CrossRefPubMed Quadri MI, Islam SI, Nasserullah Z (2000) The effect of α-thalassemia on cord blood red cell indices and interaction with sickle cell gene. Ann Saudi Med 20(5–6):367–370CrossRefPubMed
11.
Zurück zum Zitat Al Kindi S, Al Zadjali S, Al Madhani A, Daar S, Al Haddabi H, Al Abri Q, Gravell D, Berbar T, Pravin S, Pathare A, Krishnamoorthy R (2010) Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates. Hemoglobin 34(2):135–144CrossRef Al Kindi S, Al Zadjali S, Al Madhani A, Daar S, Al Haddabi H, Al Abri Q, Gravell D, Berbar T, Pravin S, Pathare A, Krishnamoorthy R (2010) Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates. Hemoglobin 34(2):135–144CrossRef
12.
13.
Zurück zum Zitat Tanphaichitr VS, Pung-amritt P, Puchaiwatananon O, Winichagoon P, Fucharoen S, Suvatte V, Wasi P (1987) Studies of hemoglobin Bart’s and deletion of alpha-globin genes from cord blood in Thailand. Birth Defects Orig Artic Ser 23(5A):15–21PubMed Tanphaichitr VS, Pung-amritt P, Puchaiwatananon O, Winichagoon P, Fucharoen S, Suvatte V, Wasi P (1987) Studies of hemoglobin Bart’s and deletion of alpha-globin genes from cord blood in Thailand. Birth Defects Orig Artic Ser 23(5A):15–21PubMed
14.
Zurück zum Zitat Kyriacou K, Kyrri A, Kalogirou E, Vasiliades P, Angastiniotis M, Ioannou PA, Kleanthous M (2000) Hb Bart’s levels in cord blood and alpha-thalassemia mutations in cyprus. Hemoglobin 24(3):171–180CrossRefPubMed Kyriacou K, Kyrri A, Kalogirou E, Vasiliades P, Angastiniotis M, Ioannou PA, Kleanthous M (2000) Hb Bart’s levels in cord blood and alpha-thalassemia mutations in cyprus. Hemoglobin 24(3):171–180CrossRefPubMed
15.
Zurück zum Zitat Rugless MJ, Fisher CA, Stephens AD, Amos RJ, Mohammed T, Old JM (2006) Hb Bart’s in cord blood: an accurate indicator of alpha-thalassemia. Hemoglobin 30(1):57–62CrossRefPubMed Rugless MJ, Fisher CA, Stephens AD, Amos RJ, Mohammed T, Old JM (2006) Hb Bart’s in cord blood: an accurate indicator of alpha-thalassemia. Hemoglobin 30(1):57–62CrossRefPubMed
16.
Zurück zum Zitat Uaprasert N, Settapiboon R, Amornsiriwat S, Sarnthammakul P, Thanapat T, Rojnuckarin P, Sutcharitchan P (2014) Diagnostic utility of isoelectric focusing and high performance liquid chromatography in neonatal cord blood screening for thalassemia and non-sickling haemoglobinopathies. Clin Chim Acta 427(1):23–26CrossRefPubMed Uaprasert N, Settapiboon R, Amornsiriwat S, Sarnthammakul P, Thanapat T, Rojnuckarin P, Sutcharitchan P (2014) Diagnostic utility of isoelectric focusing and high performance liquid chromatography in neonatal cord blood screening for thalassemia and non-sickling haemoglobinopathies. Clin Chim Acta 427(1):23–26CrossRefPubMed
Metadaten
Titel
Red Cell Indices and Hemoglobin Profile of Newborn Babies with Both the Sickle Gene and Alpha Thalassaemia in Central India
verfasst von
Dipti Upadhye
Dipty Jain
Anita Nadkarni
Kanjaksha Ghosh
Roshan Colah
Publikationsdatum
01.08.2018
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 1/2019
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-0994-1

Weitere Artikel der Ausgabe 1/2019

Indian Journal of Hematology and Blood Transfusion 1/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.